TE
Therapeutic Areas
Fennec Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Pedmark® (sodium thiosulfate injection) | Prevention of cisplatin-induced ototoxicity in pediatric patients with localized, non-metastatic solid tumors | Approved |
| Sodium Thiosulfate | Prevention of ototoxicity in newly diagnosed hepatoblastoma (Compassionate Use) | Compassionate Use |